98 related articles for article (PubMed ID: 8542425)
1. Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS.
New KC; Martuza RL; Rabkin SD
Gene Ther; 1994; 1 Suppl 1():S79. PubMed ID: 8542425
[No Abstract] [Full Text] [Related]
2. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.
Brubaker JO; Thompson CM; Morrison LA; Knipe DM; Siber GR; Finberg RW
J Immunol; 1996 Aug; 157(4):1598-604. PubMed ID: 8759744
[TBL] [Abstract][Full Text] [Related]
3. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
Yang T; Wang X; Yan Z; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer with herpes simplex vectors.
Lachmann RH; Efstathiou S
Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of neuronal physiology with defective herpes simplex virus vectors.
Neve RL; Geller AI
Adv Neurol; 1999; 79():1027-32. PubMed ID: 10514884
[No Abstract] [Full Text] [Related]
7. B-50/GAP-43 expression via a defective herpes simplex virus vector results in persistent morphological changes in non-neuronal cells.
Verhaagen J; Hermens WT; Kaplitt MG; Pfaff DW; Gispen WH
Gene Ther; 1994; 1 Suppl 1():S81. PubMed ID: 8542427
[No Abstract] [Full Text] [Related]
8. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.
Geller AI; Freese A
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1149-53. PubMed ID: 2153970
[TBL] [Abstract][Full Text] [Related]
9. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
10. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system.
Ho DY; McLaughlin JR; Sapolsky RM
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):200-9. PubMed ID: 8883953
[TBL] [Abstract][Full Text] [Related]
11. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
12. Plasmid insertion vectors that facilitate construction of herpes simplex virus gene delivery vectors.
Weir JP; Dacquel EJ
Gene; 1995 Feb; 154(1):123-8. PubMed ID: 7867939
[TBL] [Abstract][Full Text] [Related]
13. Replication-defective herpes simplex virus vectors for gene transfer in vivo.
Marconi P; Krisky D; Oligino T; Poliani PL; Ramakrishnan R; Goins WF; Fink DJ; Glorioso JC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11319-20. PubMed ID: 8876133
[No Abstract] [Full Text] [Related]
14. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.
McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ
Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors.
Brown OA; Santer RM; Shering AF; Larregina AT; Morelli AE; Southgate TD; Castro MG; Lowenstein PR
Gene Ther; 1997 Apr; 4(4):331-8. PubMed ID: 9176519
[TBL] [Abstract][Full Text] [Related]
16. Long-term expression of genes in vivo using non-replicating HSV vectors.
Bloom DC; Lokensgard JR; Maidment NT; Feldman LT; Stevens JG
Gene Ther; 1994; 1 Suppl 1():S36-8. PubMed ID: 8542391
[No Abstract] [Full Text] [Related]
17. Replication-defective recombinant herpes simplex virus vectors.
Johnson PA; Friedmann T
Methods Cell Biol; 1994; 43 Pt A():211-30. PubMed ID: 7823863
[No Abstract] [Full Text] [Related]
18. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.
Howard MK; Kershaw T; Gibb B; Storey N; MacLean AR; Zeng BY; Tel BC; Jenner P; Brown SM; Woolf CJ; Anderson PN; Coffin RS; Latchman DS
Gene Ther; 1998 Aug; 5(8):1137-47. PubMed ID: 10326038
[TBL] [Abstract][Full Text] [Related]
19. HSV vector-mediated gene delivery to the central nervous system.
Maguire-Zeiss KA; Bowers WJ; Federoff HJ
Curr Opin Mol Ther; 2001 Oct; 3(5):482-90. PubMed ID: 11699893
[TBL] [Abstract][Full Text] [Related]
20. Drug inducible transgene expression in brain using a herpes simplex virus vector.
Oligino T; Poliani PL; Wang Y; Tsai SY; O'Malley BW; Fink DJ; Glorioso JC
Gene Ther; 1998 Apr; 5(4):491-6. PubMed ID: 9614573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
